08 May Second-round tests begin on StrataGraft burn treatment developed in Madison
Posted at 15:07h
in Resident Company News
By Judy Newman, Wisconsin State Journal
A second round of studies has begun on a skin tissue product developed by a Madison company, designed to treat patients with serious burns.
The first patient has been enrolled in a Phase 2 study of StrataGraft, the skin tissue developed by Madison-based Stratatech, now part of Mallinckrodt, a global pharmaceutical company.